Update on Employer Group Waiver Plan (EGWP) Supplemental Benefits and Coverage Gap Policies for 2013 and 2014
Guidance for alerting Part D sponsors to recent bulletin from Center for Consumer Information and Insurance Oversight that addresses update to regulatory status questions concerning non-Medicare supplemental prescription drug benefits that may be offered by EGWP sponsors.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 25, 2013
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.